Galmarini CM - Search Results

1

Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia.

Galmarini CM, Graham K, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Blood. 2001 Sep 15;98(6):1922-6. doi: 10.1182/blood.v98.6.1922. Blood. 2001. PMID: 11535530 Free article.

2

Potential mechanisms of resistance to cytarabine in AML patients.

Galmarini CM, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Dumontet C. Galmarini CM, et al. Leuk Res. 2002 Jul;26(7):621-9. doi: 10.1016/s0145-2126(01)00184-9. Leuk Res. 2002. PMID: 12008078

3

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, Cros E, Dumontet C. Galmarini CM, et al. Br J Haematol. 2002 Jun;117(4):860-8. doi: 10.1046/j.1365-2141.2002.03538.x. Br J Haematol. 2002. PMID: 12060121 Free article.

4

Problems related to resistance to cytarabine in acute myeloid leukemia.

Cros E, Jordheim L, Dumontet C, Galmarini CM. Cros E, et al. Among authors: galmarini cm. Leuk Lymphoma. 2004 Jun;45(6):1123-32. doi: 10.1080/1042819032000159861. Leuk Lymphoma. 2004. PMID: 15359991 Review.

5

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, Mackey JR, Dumontet C. Galmarini CM, et al. Br J Haematol. 2003 Jul;122(1):53-60. doi: 10.1046/j.1365-2141.2003.04386.x. Br J Haematol. 2003. PMID: 12823345 Free article.

6

Nucleoside analogues and nucleobases in cancer treatment.

Galmarini CM, Mackey JR, Dumontet C. Galmarini CM, et al. Lancet Oncol. 2002 Jul;3(7):415-24. doi: 10.1016/s1470-2045(02)00788-x. Lancet Oncol. 2002. PMID: 12142171 Review.

7

Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

Galmarini CM, Jordheim L, Dumontet C. Galmarini CM, et al. Leuk Lymphoma. 2003 Jul;44(7):1105-11. doi: 10.1080/1042819031000077142. Leuk Lymphoma. 2003. PMID: 12916861 Review.

8

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J, Perigaud C, Dumontet C. Jordheim LP, et al. Among authors: galmarini cm. Clin Cancer Res. 2004 Aug 15;10(16):5614-21. doi: 10.1158/1078-0432.CCR-04-0506. Clin Cancer Res. 2004. PMID: 15328204

9

Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.

Mackey JR, Galmarini CM, Graham KA, Joy AA, Delmer A, Dabbagh L, Glubrecht D, Jewell LD, Lai R, Lang T, Hanson J, Young JD, Merle-Béral H, Binet JL, Cass CE, Dumontet C. Mackey JR, et al. Among authors: galmarini cm. Blood. 2005 Jan 15;105(2):767-74. doi: 10.1182/blood-2004-03-1046. Epub 2004 Sep 28. Blood. 2005. PMID: 15454483 Free article. Clinical Trial.

10

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters